What Tumor Dynamics Modeling Can Teach us about Exploiting the Stem-Cell View for Better Cancer Treatment

The cancer stem cell hypothesis is that in human solid cancers, only a small proportion of the cells, the cancer stem cells (CSCs), are self-renewing; the vast majority of the cancer cells are unable to sustain tumor growth indefinitely on their own. In recent years, discoveries have led to the conc...

Full description

Bibliographic Details
Main Author: Roger S. Day
Format: Article
Language:English
Published: SAGE Publishing 2015-01-01
Series:Cancer Informatics
Online Access:https://doi.org/10.4137/CIN.S17294
id doaj-b4cb5757d1554f50a0930eba5857e989
record_format Article
spelling doaj-b4cb5757d1554f50a0930eba5857e9892020-11-25T03:15:32ZengSAGE PublishingCancer Informatics1176-93512015-01-0114s210.4137/CIN.S17294What Tumor Dynamics Modeling Can Teach us about Exploiting the Stem-Cell View for Better Cancer TreatmentRoger S. Day0Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.The cancer stem cell hypothesis is that in human solid cancers, only a small proportion of the cells, the cancer stem cells (CSCs), are self-renewing; the vast majority of the cancer cells are unable to sustain tumor growth indefinitely on their own. In recent years, discoveries have led to the concentration, if not isolation, of putative CSCs. The evidence has mounted that CSCs do exist and are important. This knowledge may promote better understanding of treatment resistance, create opportunities to test agents against CSCs, and open up promise for a fresh approach to cancer treatment. The first clinical trials of new anti-CSC agents are completed, and many others follow. Excitement is mounting that this knowledge will lead to major improvements, even breakthroughs, in treating cancer. However, exploitation of this phenomenon may be more successful if informed by insights into the population dynamics of tumor development. We revive some ideas in tumor dynamics modeling to extract some guidance in designing anti-CSC treatment regimens and the clinical trials that test them.https://doi.org/10.4137/CIN.S17294
collection DOAJ
language English
format Article
sources DOAJ
author Roger S. Day
spellingShingle Roger S. Day
What Tumor Dynamics Modeling Can Teach us about Exploiting the Stem-Cell View for Better Cancer Treatment
Cancer Informatics
author_facet Roger S. Day
author_sort Roger S. Day
title What Tumor Dynamics Modeling Can Teach us about Exploiting the Stem-Cell View for Better Cancer Treatment
title_short What Tumor Dynamics Modeling Can Teach us about Exploiting the Stem-Cell View for Better Cancer Treatment
title_full What Tumor Dynamics Modeling Can Teach us about Exploiting the Stem-Cell View for Better Cancer Treatment
title_fullStr What Tumor Dynamics Modeling Can Teach us about Exploiting the Stem-Cell View for Better Cancer Treatment
title_full_unstemmed What Tumor Dynamics Modeling Can Teach us about Exploiting the Stem-Cell View for Better Cancer Treatment
title_sort what tumor dynamics modeling can teach us about exploiting the stem-cell view for better cancer treatment
publisher SAGE Publishing
series Cancer Informatics
issn 1176-9351
publishDate 2015-01-01
description The cancer stem cell hypothesis is that in human solid cancers, only a small proportion of the cells, the cancer stem cells (CSCs), are self-renewing; the vast majority of the cancer cells are unable to sustain tumor growth indefinitely on their own. In recent years, discoveries have led to the concentration, if not isolation, of putative CSCs. The evidence has mounted that CSCs do exist and are important. This knowledge may promote better understanding of treatment resistance, create opportunities to test agents against CSCs, and open up promise for a fresh approach to cancer treatment. The first clinical trials of new anti-CSC agents are completed, and many others follow. Excitement is mounting that this knowledge will lead to major improvements, even breakthroughs, in treating cancer. However, exploitation of this phenomenon may be more successful if informed by insights into the population dynamics of tumor development. We revive some ideas in tumor dynamics modeling to extract some guidance in designing anti-CSC treatment regimens and the clinical trials that test them.
url https://doi.org/10.4137/CIN.S17294
work_keys_str_mv AT rogersday whattumordynamicsmodelingcanteachusaboutexploitingthestemcellviewforbettercancertreatment
_version_ 1724638961089904640